Serial Number | 97978391 |
Word Mark | PURMINDS |
Filing Date | Wednesday, November 3, 2021 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, September 10, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 16, 2024 |
Goods and Services | Downloadable computer software programs for database management in the biotechnology field, namely, software for creating and visualizing in-silico models of biological systems, in particular 3D models of human and brain cells, and to generate new data to detail, predict and modulate complex molecular mechanisms and interactions with the systems and network levels; Downloadable software programs using artificial intelligence and machine learning for data analysis, data screening, and data processing in the fields of computational biology, In Silico experiments, robotic Microscopy, molecular assembler, brain-computer interface, bioinformatics, and neuroinformatics, to develop predictive models to accelerate drug discovery; Downloadable software applications using artificial intelligence and machine learning for data analysis for scientific and pharmaceutical product development and research purposes; downloadable software application for use in collecting and analyzing data related to neurological disorders, neurodegenerative diseases, Alzheimer's disease, and bioinformatics |
Pseudo Mark | PURE MINDS |
Goods and Services | Analyzing statistical neuroinformatic health data generated through the drug discovery process in order to uncover and identify health care fraud and claims errors |
Goods and Services | Providing medical information, consultancy and advisory services related to the treatment of neurological disorders, neurodegenerative diseases, and Alzheimer's disease; Providing information about health and wellness, namely, in the field of psychotropics, psychoactive compounds and non-psychoactive compounds and molecules; Clinical therapeutic drug monitoring, in the nature of drug use screening services for medical purposes; Medical screening and analytical services in the neuroscience field relating to the treatment of persons; remote monitoring of neuroinformatic medical data and algorithms generated through the drug discovery process for medical diagnosis and treatment |
Goods and Services | Research and development of prescriptions pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Research and development of a portfolio of psychotropics, psychoactive compounds and non-psychoactive compounds and molecules for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Laboratory analysis in the field of psychoactive drugs; Clinical laboratory testing and toxicology service, namely, molecular and endocrinology chemical analysis; medical laboratory services; laboratory testing in the nature of laboratory analysis of biologic substances for metals, occupational, and environmental toxins; Providing on-line non-downloadable software for machine learning in the fields of generating in-silico simulations of physiological responses for scientific, pharmaceutical research, product development, and educational purposes; Engineering and technical assistance in the nature of computer software consultation in the field of computer software that provides dynamic simulations of physiology for scientific, pharmaceutical research, product development, and educational purposes; Software design, engineering, and development services in the fields of artificial intelligence, machine learning, computational biology, In Silico analyses and screening, robotic Microscopy, molecular assembler, brain-computer interface, bioinformatics, neuroinformatic and consultation services related thereto |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, November 13, 2021 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, November 13, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, November 13, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 27, 2023 |
Primary Code | 045 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | PurMinds Biopharma Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Bolton, Ontario L7E1J9 CA |
Party Name | PurMinds Biopharma Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Bolton, Ontario L7E1J9 CA |
Event Date | Event Description |
Saturday, November 6, 2021 | NEW APPLICATION ENTERED |
Saturday, November 13, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, April 10, 2023 | ASSIGNED TO EXAMINER |
Wednesday, April 26, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, April 26, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, April 26, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, July 25, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Tuesday, July 25, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, October 26, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, October 26, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, October 26, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, October 26, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, October 26, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, October 27, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, November 7, 2023 | ASSIGNED TO EXAMINER |
Tuesday, December 5, 2023 | FINAL REFUSAL WRITTEN |
Tuesday, December 5, 2023 | FINAL REFUSAL E-MAILED |
Tuesday, December 5, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Thursday, February 22, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, February 22, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Wednesday, June 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, June 5, 2024 | EXPARTE APPEAL RECEIVED AT TTAB |
Wednesday, June 5, 2024 | EX PARTE APPEAL-INSTITUTED |
Wednesday, June 5, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Wednesday, June 5, 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Wednesday, June 5, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
Wednesday, June 5, 2024 | DIVISIONAL REQUEST RECEIVED |
Thursday, June 6, 2024 | DIVISIONAL PROCESSING COMPLETE |
Thursday, June 6, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, June 26, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 16, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, July 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 16, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, July 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, September 10, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Friday, June 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |